<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To further clarify the role of ribosomal protein S14 (RPS14) in <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, we examined RPS14 transcription in bone marrow derived CD34+ cells from patients with non-5q- <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> and found a reduced expression of RPS14 in 51 of 72 (71%) patients </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients with an intermediate-1 risk (INT-1) score according to the international prognostic scoring system and low RPS14 expression had a superior median overall survival of not reached versus 25 months compared to INT-1 patients with high RPS14 expression (p=0.0249) </plain></SENT>
<SENT sid="2" pm="."><plain>Using multivariate analysis, the RPS14 expression status was confirmed as an independent predictor for survival in INT-1 patients </plain></SENT>
</text></document>